Prahallad, Anirudh <br/><br/>
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs.  [electronic resource] 

 -  Cell reports  Sep 2015 
 - 1978-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2015.08.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Colonic Neoplasms--drug therapy<br/>Drug Resistance, Neoplasm--drug effects<br/>ErbB Receptors--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Vectors<br/>Genomic Library<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Indoles--pharmacology<br/>Lentivirus--genetics<br/>MAP Kinase Signaling System<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Inbred NOD<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 11--antagonists & inhibitors<br/>Proto-Oncogene Proteins B-raf--genetics<br/>RNA, Small Interfering--genetics<br/>Sulfonamides--pharmacology<br/>Transduction, Genetic<br/>Vemurafenib<br/>Xenograft Model Antitumor Assays<br/>ras Proteins--genetics